https://www.selleckchem.com/pr....oducts/LAQ824(NVP-LA
ermore, PS exacerbated the progression of myopia. To evaluate the difference in the treatment burden among different types of neovascular age-related macular degeneration (AMD). This retrospective, observational study included 431 patients who were diagnosed with neovascular AMD. Patients were divided into three groups type 1 or 2 neovascularization group (n = 167), type 3 neovascularization group (n = 5, and polypoidal choroidal vasculopathy (PCV) group (n = 214). The number of hospital visits per year and the number of an
Like
Comment
Share
